TMO EPM / Hemato H9J

61 - Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study


Listen Later

Discussão do artigo: "Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study" de Zeiser R JCO 2025

Apresentado por: Dra. Amanda Chucre

Discussão por: Dra. Ana Cecilia Bahia, Dra. Ilana Barcessat, Dr. Pedro Moraes e Dr. Vinícius Molla

...more
View all episodesView all episodes
Download on the App Store

TMO EPM / Hemato H9JBy TMO EPM / Hemato H9J